BIO from the BAYOU

👂 What if hearing loss could be the key to preventing cognitive decline? In this episode of #BIOfromtheBAYOU, host Elaine H. sits down with Celia Belline, CEO and Co-Founder of Cilcare, to explore the powerful connection between hearing and brain health. Celia shares how her company is pioneering research that could reshape how we understand aging, dementia, and neurodegenerative disease—proving that hearing health is far more than just what meets the ear. 🎧 Tune in to hear: • Why hearing loss is emerging as a leading risk factor for dementia. • How Cilcare is developing innovative therapies to protect hearing and cognition. • The future of biotech innovation in aging and neurodegeneration. 🔗 Listen now: https://lnkd.in/gTtmeU-P #Biotech #HealthcareInnovation #HearingLoss #Aging #LifeSciences #CognitiveHealth

Really enjoyed sitting down with Elaine H. and Marcus Brown to talk about the BIO on the BAYOU two-day conference happening October 28 and 29 in New Orleans. There's still time to register! Secure your spot to immerse yourself in innovative life sciences research happening in the Southeast. BONUS: turbocharge your networking by taking advantage of EBD Group's partneringOne software. You won't want to miss it! Register here: https://bioonthebayou.com/ #BIOfromtheBAYOU #BIOontheBAYOU #Biotech #Innovation #LifeSciences

I had a great time being in a podcast (my first!) with Elaine H. and Patrick Reed, RTTP about BIO on the Bayou!

🚀 What makes the Gulf South one of the most exciting—and overlooked—regions for biotech innovation? In this episode of #BIOfromtheBAYOU, Elaine H. (Tulane University School of Medicine), Patrick Reed, RTTP (Auburn University), and Marcus Brown (LSU Health Sciences Center New Orleans) share the story of how BIO on the BAYOU, returning October 28 & 29, grew from a local idea into a marquee event that connects startups, investors, universities, and global biotech leaders. 🔑 You’ll learn: • How BIO on the BAYOU became the Gulf South’s must-attend biotech conference. • Why overlooked science and startups in the region are gaining national attention. • What makes this event’s mix of panels, pitches, partnering, and New Orleans networking unique. 🎧 Tune in now and get a front-row seat to the growth of the Gulf South biotech hub: https://lnkd.in/gtTpDRBu #Biotech #Innovation #Entrepreneurship #BIOontheBAYOU #LifeSciences

🎙️ Happy #InternationalPodcastDay! From biotech strategy to startup resilience, #BIOfromtheBAYOU brings you insider conversations with key opinion leaders, founders, and investors shaping the future of life sciences. 🌎 Whether you’re a researcher, entrepreneur, or investor, our episodes deliver real-world lessons on building partnerships, securing funding, and driving biotech forward. 📲 Celebrate today by catching up on an episode—or sharing the podcast with someone who should be part of the conversation! https://lnkd.in/gwF62kBm #Biotech #LifeSciences #Podcast #StartupSuccess

Women’s health has long been underfunded and underrepresented in clinical research. So how can biotech leaders, investors, and advocates close the gap? In this #BIOfromtheBAYOU episode, host Elaine H. talks with Georgie Kovacs, MBA, Founder and CEO of Fempower Health, about the urgent need for systemic change in women’s healthcare. From reshaping clinical trials to fueling biotech innovation, Georgie shares how we can build a more equitable and impactful future for women everywhere. 🎧 Tune in to learn how biotech and women’s health can work together to drive innovation and investment: https://lnkd.in/gSGBrMXQ #Biotech #WomensHealth #ClinicalTrials #KeyOpinionLeader

🔬 Why is North Carolina becoming a powerhouse for biotech startups—and what can founders and investors everywhere learn from it? In this episode of #BIOfromtheBAYOU, host James Zanewicz, JD, LLM, RTTP, sits down with Dave Ousterout, PhD, Co-Founder and General Partner at Cape Fear BioCapital. Together, they explore the unique ecosystem fueling biotech growth in North Carolina and share practical lessons for startups navigating early-stage funding and partnerships. 💡 Key insights include: • How biotech startups can avoid early missteps and build strong foundations. • What investors really look for in early-stage biotech ventures. • Why North Carolina’s biotech ecosystem is thriving—and what that means for the industry at large. 🎧 Tune in now to hear what it takes to launch and scale biotech in today’s competitive landscape: https://lnkd.in/gNCpgaKr #Biotech #StartupFunding #NorthCarolinaBiotech #LifeSciences #VentureCapital

What makes a biotech CEO truly effective in the boardroom? In this episode of #BIOfromtheBAYOU, host Elaine H. talks with biotech board veteran Mark Corrigan M.D. who has served on and led boards across the industry. He shares candid insights on what boards look for in CEOs, the pitfalls to avoid, and how leadership qualities like humility and adaptability drive success in biotech. 🎙️ Tune in to gain insider perspectives on board dynamics and biotech leadership strategy: https://lnkd.in/g2iyEPV6 #Biotech #Leadership #KeyOpinionLeader #BoardOfDirectors #LifeSciences

What happens when biotech deals put patients—not just profits—at the center? In the latest episode of #BIOfromtheBAYOU, host James Zanewicz, JD, LLM, RTTP, talks with Sam Libby of TCB Capital Advisors about building patient-centered biotech deals. From avoiding common pitching mistakes to ensuring mission alignment, this episode explores how clinical data, strategy, and timing can drive healthcare innovation forward without leaving the patient behind. 🎧 Tune in now to learn how to create biotech deals that make a lasting impact: https://lnkd.in/g99upsek #Biotech #HealthcareInnovation #PatientAdvocacy #LifeSciences

💡 How can biotech leaders balance groundbreaking science with the tough realities of funding rare disease drug development? In this episode of #BIOfromtheBAYOU, host Elaine H. sits down with Vikas Sharma, PhD, Chief Business Officer at QurAlis, to explore: ✔️ Why genetic insights are reshaping neurodegenerative research. ✔️ Creative fundraising strategies when investors prioritize lower-risk opportunities. ✔️ How to manage board and investor relationships for long-term biotech success. Tune in for actionable lessons that can help you navigate science, business, and funding with confidence. 🎧 Listen here 👉 https://lnkd.in/gDU_eGAF #Biotech #RareDisease #DrugDevelopment #VentureCapital #KeyOpinionLeader